Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 04-oct-2026 · last seen 04-oct-2026

Dual Orexin Receptor Antagonists (DORAs)

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed review
The orexinergic crossroads: Bidirectional links between sleep-wake disturbances and the pathogenesis of Alzheimer's disease in the aging brain.
04-jun-2026 novelty 2 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18